2-(Azepan-1-yl)isonicotinic acid is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various pharmacologically active compounds. Its structure, featuring both an azepane ring and an isonicotinic acid moiety, makes it a versatile building block for designing molecules with potential therapeutic applications. It is often employed in the development of drugs targeting neurological disorders, particularly those involving modulation of neurotransmitter systems. Additionally, this compound has shown promise in the creation of novel inhibitors for enzymes or receptors associated with inflammation and cancer, contributing to ongoing research in these areas. Its role in drug discovery highlights its importance in advancing new treatments for complex diseases.